Our research will be helpful to determine the relevance of each cancer-related signaling pathways that may be used to develop novel therapies that combine extracts of P. patens with other agents including STAT, SMAD, AP-1, NF-κB, MYC, Ets, Wnt, and Hdghog blockers, to effectively treat cervical cancer, and other cancers that utilize these pathways. The gene discussed is NFKB1; the disease is cervical carcinoma.